From ‘Reverse Rett’

“As we move into this time of emerging treatments, more is demanded of us than ever, more funding, more collaboration, more challenges, more awareness campaigns, more energy and drive. This is not the time to take our eyes off the ball.

Any day now, we hope to hear news that the first in human gene therapy trial for Rett Syndrome has started. These are potential therapies that could change the trajectory of this disease for young children and significantly improve the lives of those who already live with the devastating symptoms of Rett.”

-Rachael Stevenson, CEO Reverse Rett

You can also download a copy from here